Manufacturing - Taj Pharma (Oncology)
We, at MR. A. K. Singh, are committed to manufacturing products that are hygienic. As a premier oncology manufacturer from India, we are particular about maintaining the quality of our medicines so that they match international standards. We manufacture cancer treatment medicines at affordable prices so that it is available universally to all affected patients.
As a manufacturer of medicines dedicated to treating cancer, we cover the entire gamut of medication including tablets, capsules, injections and ointments. These drugs are used in chemotherapy, immunotherapy, surgery or hormone therapy. Like other formulations, our cancer drugs are prepared under strict hygienic conditions. We maintain cleanliness of highest standards comparable to international levels. Some of the formulations processed in our works include Erlotinib, Imatinib, Capecitabine, Gefitinib and several oral anti-cancer tablets.
Treatment options of this disease include single or multiple therapies from amongst surgery, chemotherapy, radiation therapy, hormone therapy and immunotherapy. Except for radiation therapy, the other therapies are drug dependent and require superior quality formulations. Oncologic treatment varies from patient to patient, depending upon the exact location, extent of spread, stage of diagnosis and general health condition.
Cancer is a disease that involves unaccounted tissue growth forming lumps or tumors. Certain types of tumors are benign and non-cancerous, while others are malignant and life threatening. This type spreads from the primary source to other body organs through the lymphatic system. Oncology treatment involves arresting the growth of these unwanted cells and might involve one or several of these therapies. Patients suffering from cancer could have their blood, alimentary canal and hair root cells infected very fast.
Manufacture of oncologic formulations are done keeping in mind the exact form of therapy needed. The formulations and their strengths vary accordingly. Each drug is carefully examined and tested keeping in compliance with leading drug manufacturing standards. We, at S.G. Biopharm, never compromise on quality as we believe that caring for cancer patients is of superior importance and overshadows any other prerogatives. We procure ingredients from authentic sources so as to maintain highest quality standards of our products. Several tests are conducted so as to ensure genuineness of our drugs and formulations.
After manufacturing, we market these medicines through the normal process of marketing involving C&F (clearing and forwarding) agents, distributors, dealers and retailers. In addition to selling our drugs in Indian markets, we regularly export them to Middle-East, South East Asia, Africa, South America and Europe. As a leading oncology manufacturer from India, we are committed to preparing all formulations of cancer drugs.
The company is confident of quality management and quality control of its full scale production and special manufacturing facilities of, tablets and capules (beta lactam & non beta lactam), injections (beta lactam & non-beta lactam), liquid oral syrups, ophthal mic, skin care, protein powders. Thanks to strict quality measure which is maintained as per world standard in every stage of manufacturing, quality has become the benchmark of the company.
Our manufacturing unit is GMP Certified Schedule "M" compliant unit adhering to WHO GMP norms.
Taj Pharma Group
A dream for new world Anchored in India and committed to its traditional values of leadership with trust, the Taj Pharma Group is spreading its footprint globally through excellence and innovation.
Each operating company in the group develops its international business as an integral element in an overall strategy, depending on the competitive dynamics of the industry in which it operates. For some businesses a focus on the export market remains the priority. For others it is developing a robust presence in domestic markets given growing population of India. And then there are Group companies, a small but growing number, that have global ambitions; additionally, synchronizing these ventures to cater Indian market remains a priority for growth.
Exports from India remain the cornerstone of the Taj Pharma Group’s international business, but different Taj companies are increasingly investing in assets overseas through Greenfield projects (such as in Spain, Germany, Middle East, Africa, Russia, and CIS Countries), joint ventures (in Sri Lanka, UK) and acquisitions.
While individual Taj companies have differing geographical imperatives, the Taj group is focusing on a clutch of priority countries, which are expected to be of strategic importance in the years ahead. The regions are UK, Sri Lanka, the Netherlands, Germany, South Africa, members of the Gulf Cooperation Council, Brazil, Vietnam, Thailand and Taiwan.
Dr. R.K.Singh, Chairman, Taj Pharmaceuticals Limited., sums up the Taj group’s efforts to internationalize its operations thus: “We hope that a several years from now we will spread our wings far beyond India, that we become a global group, operating in many countries, an Indian business conglomerate that is at home in the world, carrying the same sense of trust that we do today." We have already progressed on such efforts by our current presence in more than 40 countries.